A significant challenge in genetic engineering has been the development of an effective delivery mechanism for cancer treatments utilizing Clostridium, ensuring appropriate secretion of therapeutic agents such as TNF-α or enzymes like CD (Cytosine deaminase) to function directly within the tumor microenvironment. This evidence concerns the gene CTLA4 and cancer.